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Oral Presentation 1.4 
EFFECTS OF CHRONIC INJECTIONS OF THE AMYLOID 
FRAGMENT, 8A(25-35) INTO THE MEDIAL SEPTAL AREA ON 
LEARNING AND MEMORY IN THE MALE RAT 
Greg Tinkler and Wayne Dornan*, Department of Psychology, lWU 
Alzheimer's Disease (AD), a neurodegenerative disorder associated with loss 
of neurons in the brain, is the most frequent cause of dementia in the elderly, 
accounting for more than 20 million cases worldwide. Despite a 20 fold 
increase in the number of reported deaths between 1979 and 1993, presently 
there is no cure or treatment for AD. While the mechanism of neuronal 
atrophy in AD is unknown, pathologically, AD is characterized by 
extracellular deposition of neuritic plaques (NP) and a generation of 
neurofibrillary tangles typically found in the cerebral cortex, hippocampus, 
and basal forebrain. Accumulating evidence suggests that the maj or 
constituent of NP, a beta-amyloid protein composed of 39-42 amino acids 
possesses neurotoxic properties. In a previous study done in our laboratory 
(Neuroreport 1993), we reported that bilateral inj ections of BA(25-35) into 
the hippocampus together with a subthreshold dose of IBO (which by itself 
has no neurotoxic effects) produced a dramatic disruption in the acquisition of 
spatial learning in the rat. In contrast, bilateral inj ections into the 
hippocampus of two different doses of BA(25-35) or the incubated form of 
BA(25- 35) failed to significantly affect maze acquisition in the rat. Therefore, 
research done in our laboratory has failed to reveal any effects on spatial 
learning and memory in the rat following intrahippocampal inj ections of 
BA(25-35)  alone. Collectively, this suggests that BA(25-35)  is not directly 
neurotoxic to hippocampal neurons, but either increases their vulnerability to 
further insult or acts upon other neurons which synapse upon the 
hippocampus. An alternative hypothesis is that since the accumulation of 
amyloid plaques is a gradual process, single injections of BA(25-35)  might not 
be expected to induce significant hippocampal damage. Recently it has been 
reported medial septal injections of BA(25-35) induced a significant reduction 
of hippocampal choline acetyltransferase (ChAT) without significantly 
altering the number of non-cholinergic neurons proj ecting to the 
hippocampus. This depletion in ChAT was significant on the seventh day 
postinjection, but had disappeared by day 21. However, no behavioral tests 
were performed to determine whether any impairments in learning and 
memory could be correlated to the degree of depletion. The aim of this study 
was to assess whether multiple injections of BA(25-35) into the medial septal 
area would cause a sustained reduction in acetylcholine input to the 
hippocampus and produce a concomitant disruption in learning and memory. 
